Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

Conditions: MRI Scan Interventions: Drug: MT218 injection Sponsors: Molecular Theranostics LLC; Emory University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials